512 related articles for article (PubMed ID: 26372964)
21. Co-Expression of Glia Maturation Factor and Apolipoprotein E4 in Alzheimer's Disease Brain.
Thangavel R; Bhagavan SM; Ramaswamy SB; Surpur S; Govindarajan R; Kempuraj D; Zaheer S; Raikwar S; Ahmed ME; Selvakumar GP; Iyer SS; Zaheer A
J Alzheimers Dis; 2018; 61(2):553-560. PubMed ID: 29172001
[TBL] [Abstract][Full Text] [Related]
22. ApoE4 Accelerates Early Seeding of Amyloid Pathology.
Liu CC; Zhao N; Fu Y; Wang N; Linares C; Tsai CW; Bu G
Neuron; 2017 Dec; 96(5):1024-1032.e3. PubMed ID: 29216449
[TBL] [Abstract][Full Text] [Related]
23. Reduced levels of human apoE4 protein in an animal model of cognitive impairment.
Sullivan PM; Han B; Liu F; Mace BE; Ervin JF; Wu S; Koger D; Paul S; Bales KR
Neurobiol Aging; 2011 May; 32(5):791-801. PubMed ID: 19577821
[TBL] [Abstract][Full Text] [Related]
24. Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer's disease patients.
Ji Y; Gong Y; Gan W; Beach T; Holtzman DM; Wisniewski T
Neuroscience; 2003; 122(2):305-15. PubMed ID: 14614898
[TBL] [Abstract][Full Text] [Related]
25. Cellular source-specific effects of apolipoprotein (apo) E4 on dendrite arborization and dendritic spine development.
Jain S; Yoon SY; Leung L; Knoferle J; Huang Y
PLoS One; 2013; 8(3):e59478. PubMed ID: 23527202
[TBL] [Abstract][Full Text] [Related]
26. Abeta-independent roles of apolipoprotein E4 in the pathogenesis of Alzheimer's disease.
Huang Y
Trends Mol Med; 2010 Jun; 16(6):287-94. PubMed ID: 20537952
[TBL] [Abstract][Full Text] [Related]
27. Impaired Autophagy in APOE4 Astrocytes.
Simonovitch S; Schmukler E; Bespalko A; Iram T; Frenkel D; Holtzman DM; Masliah E; Michaelson DM; Pinkas-Kramarski R
J Alzheimers Dis; 2016; 51(3):915-27. PubMed ID: 26923027
[TBL] [Abstract][Full Text] [Related]
28. Amyloid clearance defect in ApoE4 astrocytes is reversed by epigenetic correction of endosomal pH.
Prasad H; Rao R
Proc Natl Acad Sci U S A; 2018 Jul; 115(28):E6640-E6649. PubMed ID: 29946028
[TBL] [Abstract][Full Text] [Related]
29. Lipid Dys-Homeostasis Contributes to APOE4-Associated AD Pathology.
Lazar AN; Hanbouch L; Boussicaut L; Fourmaux B; Daira P; Millan MJ; Bernoud-Hubac N; Potier MC
Cells; 2022 Nov; 11(22):. PubMed ID: 36429044
[TBL] [Abstract][Full Text] [Related]
30. Epidermal growth factor prevents APOE4 and amyloid-beta-induced cognitive and cerebrovascular deficits in female mice.
Thomas R; Zuchowska P; Morris AW; Marottoli FM; Sunny S; Deaton R; Gann PH; Tai LM
Acta Neuropathol Commun; 2016 Oct; 4(1):111. PubMed ID: 27788676
[TBL] [Abstract][Full Text] [Related]
31. Differential Binding of Human ApoE Isoforms to Insulin Receptor is Associated with Aberrant Insulin Signaling in AD Brain Samples.
Chan ES; Chen C; Soong TW; Wong BS
Neuromolecular Med; 2018 Mar; 20(1):124-132. PubMed ID: 29450841
[TBL] [Abstract][Full Text] [Related]
32. APOΕ4 lowers energy expenditure in females and impairs glucose oxidation by increasing flux through aerobic glycolysis.
Farmer BC; Williams HC; Devanney NA; Piron MA; Nation GK; Carter DJ; Walsh AE; Khanal R; Young LEA; Kluemper JC; Hernandez G; Allenger EJ; Mooney R; Golden LR; Smith CT; Brandon JA; Gupta VA; Kern PA; Gentry MS; Morganti JM; Sun RC; Johnson LA
Mol Neurodegener; 2021 Sep; 16(1):62. PubMed ID: 34488832
[TBL] [Abstract][Full Text] [Related]
33. Differential Effects of apoE4 and Activation of ABCA1 on Brain and Plasma Lipoproteins.
Boehm-Cagan A; Bar R; Harats D; Shaish A; Levkovitz H; Bielicki JK; Johansson JO; Michaelson DM
PLoS One; 2016; 11(11):e0166195. PubMed ID: 27824936
[TBL] [Abstract][Full Text] [Related]
34. A SAGE study of apolipoprotein E3/3, E3/4 and E4/4 allele-specific gene expression in hippocampus in Alzheimer disease.
Xu PT; Li YJ; Qin XJ; Kroner C; Green-Odlum A; Xu H; Wang TY; Schmechel DE; Hulette CM; Ervin J; Hauser M; Haines J; Pericak-Vance MA; Gilbert JR
Mol Cell Neurosci; 2007 Nov; 36(3):313-31. PubMed ID: 17822919
[TBL] [Abstract][Full Text] [Related]
35. CSF tau is associated with impaired cortical plasticity, cognitive decline and astrocyte survival only in APOE4-positive Alzheimer's disease.
Koch G; Di Lorenzo F; Loizzo S; Motta C; Travaglione S; Baiula M; Rimondini R; Ponzo V; Bonnì S; Toniolo S; Sallustio F; Bozzali M; Caltagirone C; Campana G; Martorana A
Sci Rep; 2017 Oct; 7(1):13728. PubMed ID: 29062035
[TBL] [Abstract][Full Text] [Related]
36. Detection of early Alzheimer's disease-like molecular alterations in a mouse model expressing human ApoE4.
Rai A; Ojiakor OA; Rylett RJ
J Neurochem; 2023 Aug; 166(3):572-587. PubMed ID: 37415276
[TBL] [Abstract][Full Text] [Related]
37. Vascular ApoE4 Impairs Behavior by Modulating Gliovascular Function.
Yamazaki Y; Liu CC; Yamazaki A; Shue F; Martens YA; Chen Y; Qiao W; Kurti A; Oue H; Ren Y; Li Y; Aikawa T; Cherukuri Y; Fryer JD; Asmann YW; Kim BYS; Kanekiyo T; Bu G
Neuron; 2021 Feb; 109(3):438-447.e6. PubMed ID: 33321072
[TBL] [Abstract][Full Text] [Related]
38. APOE4 enhances age-dependent decline in cognitive function by down-regulating an NMDA receptor pathway in EFAD-Tg mice.
Liu DS; Pan XD; Zhang J; Shen H; Collins NC; Cole AM; Koster KP; Ben Aissa M; Dai XM; Zhou M; Tai LM; Zhu YG; LaDu M; Chen XC
Mol Neurodegener; 2015 Mar; 10():7. PubMed ID: 25871877
[TBL] [Abstract][Full Text] [Related]
39. The influence of chronic stress on anxiety-like behavior and cognitive function in different human GFAP-ApoE transgenic adult male mice.
Meng FT; Zhao J; Fang H; Liu YJ
Stress; 2015; 18(4):419-26. PubMed ID: 25938810
[TBL] [Abstract][Full Text] [Related]
40. Human ApoE ɛ2 Promotes Regulatory Mechanisms of Bioenergetic and Synaptic Function in Female Brain: A Focus on V-type H+-ATPase.
Woody SK; Zhou H; Ibrahimi S; Dong Y; Zhao L
J Alzheimers Dis; 2016 Jun; 53(3):1015-31. PubMed ID: 27340853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]